Published in Cancer Weekly, November 9th, 1998
K. Takahashi and colleagues from the University of Tokushima, Japan, examined the effect of OK-432 on the induction of CTLs directed against autologous tumor cells (ATC) and LAK cells from the mononuclear cells separated from regional lymph node cells (RLMNCs) of lung cancer patients. Samples were tested from forty-nine patients ("OK-432 Develops CTL and LAK Activity in Mononuclear Cells from Regional Lymph Nodes of Lung Cancer Patients," International Journal of Immunopharmacology, August...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.